First Light Biosciences develops innovative diagnostic tests that enable rapid and accurate detection of pathogens that can cause life-threatening infections. Our antimicrobial susceptibility tests will help ensure that patients suffering from infection receive appropriate antibiotic treatment options in hours and not days compared to current practices. Leveraging our highly differentiated MultiPath™ technology, our products strive to save lives, lower healthcare costs, improve antibiotic stewardship, and prevent the spread of antibiotic drug-resistance.
Company’s Keywords:
<27
<
<
<